Long-term follow-up for adolescents from the PRALIMAP-INÈS program
Post-interventional Future for Adolescents From the PRALIMAP-INÉS Trial
This study looks at how former participants from a program for overweight adolescents are doing in their health, education, and social lives as they grow into young adults.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 852 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Central Hospital, Nancy, France Academic / other |
| Locations | 1 site (Nancy) |
| Trial ID | NCT05386017 on ClinicalTrials.gov |
What this trial studies
This research follows up on participants from the PRALIMAP-INÈS cohort to assess their long-term social, economic, educational, and health trajectories as they transition into young adulthood. The study involves contacting former participants to collect updated anthropometric measurements and health data, as well as conducting qualitative interviews to explore the social factors influencing their health behaviors. The follow-up includes a questionnaire and a visit to a medical center near the participants' current locations. This fourth measurement time aims to provide insights into the effectiveness of previous interventions on managing overweight and obesity in adolescents.
Who should consider this trial
Good fit: Ideal candidates for this study are young adults who previously participated in the PRALIMAP-INÈS trial and are now over 18 years old.
Not a fit: Patients who did not participate in the PRALIMAP-INÈS trial or those who are not receiving social security benefits may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term impacts of early interventions for overweight and obesity in adolescents, potentially guiding future health strategies.
How similar studies have performed: While this study builds on previous findings from the PRALIMAP-INÈS trial, it introduces a novel long-term follow-up component that has not been extensively tested in similar cohorts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * As part of the cohort follow-up, all young adults who participated in the PRALIMAP-INÈS trial will be contacted again. Each young adult: Was enrolled in 3rd or 2nd grade in 2012, 2013 or 2014 in the participating schools in the PRALIMAP-INÈS program (T3: over 18 years old). years old) * Participated in the PRALIMAP-INÈS trial, and thus was considered eligible for this trial trial (with a BMI above the IOTF threshold (Cole et al. 2000) of reduced overweight of 1 kg/m² for age and sex and/or an abdominal circumference greater than the McCarthy McCarthy cut-offs for age and sex (McCarthy, Jarrett, and Crawley 2001) and having received a medical interview) * Is enrolled in or receiving social security benefits Exclusion Criteria: * As part of the cohort follow-up, there are no non-inclusion criteria.
Where this trial is running
Nancy
- CHRU de Nancy — Nancy, France (Recruiting)
Study contacts
- Principal investigator: Yacoubou OMOROU — Central Hospital, Nancy, France
- Study coordinator: Yacoubou OMOROU
- Email: Y.OMOROU@chru-nancy.fr
- Phone: 0383859303
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.